US2002044978A1PendingUtilityA1

Method of manufacture of garlic extract for use as a preventive and therapeutic agent for human prostate and bladder cancers

Priority: Apr 12, 2000Filed: Nov 16, 2001Published: Apr 18, 2002
Est. expiryApr 12, 2020(expired)· nominal 20-yr term from priority
A61K 31/10A61K 36/9062A61K 36/8962
35
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention is concerned with clinical investigation of therapeutic effects of garlic extracts containing allicin, diallyl disulfide, and diallyl trisulfide. Because the intake of garlic or therapeutically active substance such as allicin from garlic, induces immunostimulation and possess strong antitumor effects concomitant with apoptosis of tumors that can in turn induces a programmed cell death of human prostatic and bladder tumor cells. This invention claims that garlic and/or garlic extracts possess very effective therapeutic substances not only to treat human prostate and bladder cancers to extend life span of patients, but also to suppress or prevent bladder and prostate gland cancers.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A chemopreventive and chemotherapeutic composition against human prostate cancers comprising allicin-containing garlic extracts isolated and purified from garlic, as an effective ingredient.  
     
     
         2 . A chemopreventive and chemotherapeutic composition against human bladder cancers comprising allicin-containing garlic extracts isolated and purified from garlic, as an effective ingredient.

Join the waitlist — get patent alerts

Track US2002044978A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.